Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sandvig-Pharma ApS
APS
Active
Advertising protection
CVR 40667687
Kirkeplads 8, 6200
Aabenraa
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2019 · 6 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Sandvig-Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
-1M
2023
-3M
2024
-5M
2025
EBITDA
DKK millions
0M
-2M
-3M
-5M
-6M
0M
2021
0M
0%
2022
-1M
-100%
2023
-3M
-200%
2024
-5M
-67%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
—
-423
-1.235
-3.283
-4.539
Staff expenses
-0
-0
-0
-116
-572
EBITDA
0
-423
-1.235
-3.399
-5.112
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
0
-423
-1.235
-3.399
-5.112
Net financials
0
0
-2
-2
-1
Profit before tax
0
-734
-9.954
-7.135
-5.113
Tax
-0
-162
-2.190
-1.569
-1.125
Net profit
0
-573
-7.764
-5.566
-3.988
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
50
354
3.426
6.292
7.237
Equity
50
-523
-8.288
-13.854
-17.842
Long-term debt
0
0
0
0
0
Short-term debt
0
877
11.714
20.146
25.079
Total debt
0
877
11.714
20.146
25.079
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-511159300.0%
This company
2021
2025
Equity ratio
-246.5%
This company
38.2%
Market median
-745% vs market
2021
2025
Return on equity
-398802900.0%
This company
18.4%
Market median
-2167407165% vs market
2021
2025
Net profit margin (of gross profit)
-398802900.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.63×
This company
2021
2025
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-05-01 – 2021-06-30
View
PDF
More on Sandvig-Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
